Related Experiment Video
Updated: Feb 4, 2026

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
The predictive role of protease-activated receptor (PAR-1) polymorphisms and activated microplatelets on the severity
Urszula Jakobsche-Policht1, Agnieszka Bronowicka-Szydełko2, Rajmund Adamiec3
1Department of Angiology and Internal Diseases, Institute of Internal Diseases, Wroclaw Medical University, Wroclaw, Poland.
Abstract:
This study is a comprehensive analysis of PAR-1 - involved in thrombin interaction with platelets (PLT), present on PLT and microparticles (PMP) - to understand its role in diabetic macroangiopathy (DM) and atherosclerosis obliterans (AO). The applied RT-PCR, aggregometry, flow cytometry, a proprietary method for PMP level determination, ELISA, and multidimensional statistical analysis allowed for the determination of: PAR-1 activation levels, its polymorphisms, PLT/PMP aggregation capacity, hemostatic factors, and their interrelationships. In DM, the -506D/D and IVS-14A/A polymorphisms were significantly more frequent, whereas the -506I/D was much more common in AO, suggesting the protective properties of the I allele and its potential significance as a prognostic factor for a milder course of atherosclerosis. Similarly, increased PMP activity in DM indicates that activated PMP contribute to the atherosclerosis progression. A probable explanation for the reduced PAR-1 activation in AO is its association with the observed lower levels of von Willebrand factor. Interaction analysis showed that although the percentage of PMP did not affect the odds of AO (among AO and DM), at high PMP percentages, increased PAR-1 activation became a factor elevating the AO odds. Quantitative assessment of PAR-1 and PMP allows for predicting the severity of atherosclerosis.
Related Concept Videos
Co-activators and Co-repressors
Predicting Products: SN1 vs. SN2
With increased substitution on the alkyl halide,...
tRNA Activation
Activation Energy
Secondary Active Transport
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...

